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Introduction 
Eosinophilic fasciitis is a rare disorder of unknown 
etiology that leads to progressive and sometimes 
disabling induration of the skin and connective 
tissue. Eosinophilic fasciitis was first described in 
1974 [1] and since then, over 300 cases have been 
reported across the world [2]. Although the 
pathophysiology is still unknown, specific triggers 
have been reported, such as vigorous activity, 
medications, or infection [3]. Although eosinophilic 
fasciitis commonly presents symmetrically with 
distinct morphologic features, we describe an 
unusual solitary plaque with pathologic features 
consistent with eosinophilic fasciitis. 
 
Case Synopsis 
A 16-year-old previously healthy female athlete 
presented with acute worsening of an 8-month old 
painful plaque on her right thigh after competing in 
a cross-country competition. She had been treated 
by her primary care physician with minocycline 
100mg daily and topical clobetasol 0.05% ointment 
twice daily for six months prior to presenting in our 
clinic. During her visit, she described increased pain 
and induration of her plaque. She denied taking any 
additional medications, history of medical 
conditions, or recent illness. She endorsed a family 
history of granulomatosis with polyangiitis in her 
grandfather. 
Upon presentation, physical examination revealed a 
13×10cm firm, indurated plaque with no overlying 
epidermal changes on the right upper thigh (Figure 
1). No other cutaneous, mucosal, or joint findings 
were noted. Given the localized unilateral 
appearance of the lesion on the proximal lower 
extremity, a working diagnosis of morphea was 
favored. Biopsy revealed thickening of the fibrous 
septae of the subcutis with an inflammatory infiltrate 
consisting of lymphocytes, plasma cells, histiocytes,  
Abstract 
Eosinophilic fasciitis is a rare connective tissue 
disorder characterized by inflammation of the fascia 
that leads to painful, indurated skin. Because of its 
variable clinical presentation and overlap with 
conditions, such as morphea, the diagnosis of 
eosinophilic fasciitis can be challenging and relies on 
clinical presentation, histopathologic and laboratory 
analysis, and response to therapy. Herein, we present 
an unusual, solitary, isolated plaque with pathologic 
features and response to therapy most consistent 
with eosinophilic fasciitis.  
 
Figure 1. A) Solitary indurated plaque on the upper right 
thigh. B) Close-up of induration. 
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and prominent eosinophils consistent with 
eosinophilic fasciitis (Figure 2). The epidermis and 
dermis were spared. Focal lymphoid follicles and fat 
necrosis were also evident. 
Given the classic histological findings, the diagnosis 
of eosinophilic fasciitis was made. Minocycline was 
discontinued and the patient was started on a one-
month oral prednisone taper starting at 40mg daily 
while continuing topical clobetasol 0.05% ointment 
twice daily. At three-week follow-up, she noted 
dramatic improvement in symptoms with no further 
pain and decreased induration. However, one month  
after completion of her prednisone taper, pain in the 
area began to return. An additional one-month 
prednisone taper was completed with resolution of 
symptoms without further recurrence. Five months 
after initial presentation, the patient remains pain-
free and continues to run in cross-country 
competitions. 
 
Case Discussion 
Eosinophilic fasciitis, initially referred to as Shulman 
syndrome, has often been regarded as part of the 
  
 
  
 
Figure 2. A-C) Biopsy revealed prominent septal thickening and fibrosis in the subcutis accompanied by inflammatory infiltrates, 
including C, D) lymphocytes, plasma cells (green arrows), histiocytes, and prominent eosinophils (black arrows). A) 20×; B) 100×; 
C, D) 400×. 
A B
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morphea spectrum [4]. The pleomorphic clinical 
appearance of eosinophilic fasciitis and its 
overlapping features with other sclerotic conditions 
can make clinical diagnosis challenging and can 
often cause delay in diagnosis. This is evident as an 
overwhelming 79% of eosinophilic fasciitis patients 
are initially misdiagnosed [5]. Further complicating 
clinical judgement, about one-third of patients 
report concurrent existence of both eosinophilic 
fasciitis and morphea [5-7]. Despite this overlap, 
there are several distinguishing features between 
eosinophilic fasciitis and morphea (Table 1). 
Classic findings in early eosinophilic fasciitis appear 
as edema, followed by ‘peau d’orange’ dimpling with 
hyperpigmentation, and subsequent painful 
induration and thickening of the skin. Additionally, 
patients with eosinophilic fasciitis may display the 
‘groove sign,’ denoting depressions on the skin 
overlying veins that are accentuated with limb 
elevation. Eosinophilic fasciitis usually presents 
symmetrically favoring the distal extremities but 
may additionally appear on the trunk, back, buttocks, 
face, or neck [6]. In contrast, morphea classically 
presents as a smooth yellow-white sclerotic plaque, 
typically unilateral and on the trunk or proximal 
extremities [8]. Thus, morphea was initially 
suspected in our patient given the exuberant clinical 
appearance of a smooth indurated plaque with 
proximal and unilateral limb localization. 
Although clinical appearances can be misleading, 
histopathologic studies can provide diagnostic value 
to help distinguish eosinophilic fasciitis from 
morphea. The gold standard for diagnosis of 
eosinophilic fasciitis requires skin-to-muscle biopsy; 
however, in this case, subcutaneous tissue was able 
to provide sufficient evidence for diagnosis. 
Typically, histopathology of eosinophilic fasciitis 
reveals a thickened fascia with inflammatory 
infiltrate composed of lymphocytes, plasma cells, 
histiocytes, and eosinophils [9]. Eosinophil infiltrates 
have been reported in as high as 80% of patients but 
is not required for diagnosis [6, 10, 11]. In contrast, 
histologic evaluation of morphea usually reveals a 
perivascular infiltrate with lymphocytes and plasma 
cells with thickened collagen bundles, primarily 
focused in the papillary and reticular dermis [4]. 
Table 1. Clinical features of eosinophilic fasciitis and plaque morphea. 
 
Features Eosinophilic Fasciitis Plaque Morphea 
Onset with physical 
exertion Common Uncommon 
Clinical appearance  
Edema, followed by ‘peau d’orange’ dimpling with 
hyperpigmentation, progressing to a painful 
induration and thickening of the skin 
Violaceous/erythematous lesion, 
progressing into a smooth yellow-white 
sclerotic plaque surrounded by a violaceous 
rim (‘lilac ring’) 
‘Groove sign’ overlying 
veins Present Absent 
Location Most commonly found on extremities Most commonly found on trunk  
Localization Symmetric, distal Unilateral, proximal 
Peripheral Eosinophilia Common Uncommon 
Skin Histology Usually involvement of fascia, eosinophils present; dermal and epidermal sparing 
Dermal thickening and fibrosis with 
epidermal atrophy; rarely eosinophils 
Extracutaneous 
manifestations 
Joint contractures (50-67%), inflammatory arthritis 
(40%), carpal tunnel syndrome (17-23%) [3, 5, 6] 
Arthralgias (19%), myalgias (14%), joint 
swelling (10%), limb contractures (2%), [13] 
Treatment 
Initial therapy usually requires systemic steroids. 
Additional therapies include oral methotrexate, 
mycophenolate mofetil, and phototherapy 
Initial therapy is systemic steroid-sparing, 
including topical tacrolimus, 
topical/intralesional corticosteroids, 
phototherapy, and oral methotrexate  
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Specifically, in our patient, septal fibrosis and mixed 
inflammatory infiltrates, including abundant 
eosinophils in the subcutis with dermal and 
epidermal sparing, favored the diagnosis of 
eosinophilic fasciitis over morphea. Although not 
diagnostic, associated laboratory abnormalities of 
peripheral eosinophilia and hypergammaglobulinemia 
may also provide additional information to support 
the diagnosis of eosinophilic fasciitis [12]. 
The mainstay of treatment for eosinophilic fasciitis 
includes oral corticosteroid monotherapy. 
Delineating these two conditions is imperative as 
morphea may require more long-term therapy with 
steroid-sparing agents, such as methotrexate, 
whereas systemic steroid therapy may be required 
for more severe or generalized cases (Table 1), [4]. 
Early recognition and proper treatment of 
eosinophilic fasciitis is critical in preventing 
complications from disease progression leading to 
joint contractures, which may affect over half of 
patients with eosinophilic fasciitis [3, 5, 6]. 
Hematologic malignancies and solid malignant 
tumors have been associated with eosinophilic 
fasciitis [3, 6, 7], lending further support to the 
necessity of early diagnosis of this disease. 
Although eosinophilic fasciitis is a rare disease, its 
similarity to cutaneous manifestations of other 
diseases has raised the question that the prevalence 
of this disease may be higher than previously 
reported owing to misdiagnosis [3]. Further 
exploration of these two conditions is necessary to 
distinguish the clinical classification and etiology of 
these pathologies.  
 
Conclusion 
In summary, we present a patient with eosinophilic 
fasciitis confirmed by histology with an unusual 
clinical presentation as a unilateral solitary plaque. 
Clinicians should be aware of the clinical variability of 
eosinophilic fasciitis mimicking morphea, as well as 
eruptions of other sclerotic etiologies. Thus, it is 
important for clinicians to have an accurate clinical 
concept of both eosinophilic fasciitis and morphea in 
order to provide appropriate treatment for patients. 
This may lead to decreased misdiagnosis and 
improved patient outcomes. 
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